Two Clinical Trials Assessing Treatments for Eosinophilic Esophagitis. Reply

Affiliations

¹ Cincinnati Children's Hospital Medical Center, Cincinnati, OH marc.rothenberg@cchmc.org.
² University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC.
³ Cincinnati Children's Hospital Medical Center, Cincinnati, OH.

Comment

Marc E Rothenberg et al. N Engl J Med. 2024.

. 2024 Sep 19;391(11):1067-1068.

doi: 10.1056/NEJMc2409416.

¹ Cincinnati Children's Hospital Medical Center, Cincinnati, OH marc.rothenberg@cchmc.org.
² University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC.
³ Cincinnati Children's Hospital Medical Center, Cincinnati, OH.

No abstract available

Comment on

Dupilumab for Eosinophilic Esophagitis in Patients 1 to 11 Years of Age.
Chehade M, Dellon ES, Spergel JM, Collins MH, Rothenberg ME, Pesek RD, Hirano I, Liu R, Laws E, Mortensen E, Martincova R, Shabbir A, McCann E, Kamal MA, Kosloski MP, Hamilton JD, Samuely C, Lim WK, Wipperman MF, Farrell A, Patel N, Yancopoulos GD, Glotfelty L, Maloney J. Chehade M, et al. N Engl J Med. 2024 Jun 27;390(24):2239-2251. doi: 10.1056/NEJMoa2312282. N Engl J Med. 2024. PMID: 38924731 Clinical Trial.